Dawaa Reference

Clinical reference

Cardiovascular neoplasm

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class KD25 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care · StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK430685/

Verified against1 document
  • No dose - referral pathway, no medicine given in primary care

Verified date2026-08

Presentation reference

Is it this?

Reference only, to read alongside your own examination.

Symptoms — what the patient reports (5)

  • Symptoms are vague and creep up slowly, so diagnosis and surgery are often late
  • Trouble comes from a leaking or blocked valve, or from flow blocked inside the heart
  • Fluid round the heart with tamponade, an abnormal rhythm, or congestive heart failure
  • A growing share cause nothing at all and turn up by chance on a scan
  • What shows depends on how big the tumour is, where it sits, how fast it grows and how far it invades

Tests (12)

  • Unless it is taken out, most cardiac masses cannot be named with certainty
  • Echocardiography is the key test: up to 90% sensitive and specific, and done at the bedside
  • Echo gives size, mobility, spread, relation to neighbouring structures, and any obstruction or valve leak
  • The transoesophageal view brings out small tumours the surface scan left unclear
  • Contrast echo separates a tumour from a clot; 3D echo adds shape and structural involvement
  • Cardiac MRI resolves better than echo and characterises the tissue itself
  • No late gadolinium uptake points to a clot rather than a tumour
  • In small series, MRI told benign from malignant with up to 79% accuracy
  • Fat-suppression sequences pick out fatty tumours such as lipoma and liposarcoma
  • A myxoma is dark on T1 and takes up little contrast, the picture of a poorly vascular benign lesion
  • CT reads the mass by its x-ray density, shows calcium in it, and finds small masses
  • Left heart catheterisation maps the tumour blood supply and any invasion of the surface coronary vessels

If not this — what else fits (4)

  • A clot or an infected vegetation can look the same as a tumour on imaging
  • With a device or prosthesis in place plus infection, a vegetation becomes the likelier answer
  • Heart failure in a cancer patient may be chemotherapy damage rather than tumour spread
  • Infection alone can raise masses inside the heart or the pericardium, or an effusion

SourceStatPearls "Cardiac Tumors" - disease-level clinical article

Presentation findings are traced to the source above.

1

NO DRUG THERAPY IN PRIMARY CARE (REFERRAL & ADVICE)

1st line
Adult dose and duration

Tumours of the heart or blood vessels are rare and need cardiology or cardiothoracic surgery referral for imaging and biopsy or excision; this is a recognise-and-refer category with no primary-care drug treatment. - Refer, with advice

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

Tumours of the heart or blood vessels are rare and need cardiology or cardiothoracic surgery referral for imaging and biopsy or excision; this is a recognise-and-refer category with no primary-care drug treatment.

Cautions
  • RED FLAG - Constitutional tumor symptoms (fever, weight loss, elevated ESR) mimicking endocarditis: assess urgently and refer.
  • RED FLAG - Hemodynamic obstruction (positional syncope, acute pulmonary edema): assess urgently and refer.
  • New murmur with embolic events, unexplained heart failure, or a palpable vascular mass are indications for urgent specialist referral.
  • Rare in Egyptian primary care.
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.